References
- Jenks PJ, Laurent M, McQuarry S, Watkins R. Clinical and economic burden of surgical site infection (SSI) and predicted financial consequences of elimination of SSI from an English hospital. J Hosp Infect 2014;86:24–33.
- Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20: 725–30.
- Nelson RL, Gladman E, Barbateskovic M. Antimicrobial prophylaxis for colorectal surgery. The Cochrane database of systematic reviews. 2014;5:CD001181.
- Wilson AP, Hodgson B, Liu M, Plummer D, Taylor I, Roberts J, et al. Reduction in wound infection rates by wound surveillance with postdischarge follow-up and feedback. Br J Surg 2006;93:630–8.
- Public Health England. Surveillance of surgical site infections in NHS hospitals in England, 2013/14. Public Health England; 2014.
- Tanner J, Khan, D, Aplin C, Ball J, Thomas, M, Bankart J. Post-discharge surveillance to identify colorectal surgical site infection rates and related costs. J Hosp Infect 2009;72: 243–50.
- Kang CY, Chaudhry OO, Halabi WJ, Nguyen V, Carmichael JC, Mills S, et al. Risk factors for postoperative urinary tract infection and urinary retention in patients undergoing surgery for colorectal cancer. Am Surg 2012;78:1100–4.
- Health Protection Agency. English National Point Prevalence Survey on Healthcare Associated Infections and Antimicrobial Use, 2011: Preliminary data. HPA; 2012.
- Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Swedish Rectal Cancer Trial Group. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 2005;23:8697–705.
- Poston GJ, Tait D, O’Connell S, Bennett A, Berendse S; Guideline Development Group. Diagnosis and management of colorectal cancer: summary of NICE guidance. BMJ 2011; 343:d6751.
- Gagliardi AR, Fenech D, Eskicioglu C, Nathens AB, McLeod R. Factors influencing antibiotic prophylaxis for surgical site infection prevention in general surgery: a review of the literature. Can J Surg 2009;52:481–9.
- Moine P, Fish DN. Pharmacodynamic modelling of intravenous antibiotic prophylaxis in elective colorectal surgery. Int J Antimicrob Agents 2013;41:167–73.
- Schäfer M, Clavien PA. A meta-analysis of randomized controlled trials assessing the prophylactic use of ceftriaxone. A study of wound, chest and urinary infections. World J Surg 2009;33:2551–2.
- Tang R, Chen HH, Wang YL, Changchien CR, Chen JS, Hsu KC, et al. Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2,809 consecutive patients. Ann Surg 2001;234:181–9.
- Tsujinaka S, Konishi F. Drain vs no drain after colorectal surgery. Indian J Surg Oncol 2011;2:3–8.
- Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect 2010; 11:79–109.
- Lawson EH, Hall BL, Ko CY. Risk factors for superficial vs deep/organ-space surgical site infections: implications for quality improvement initiatives. JAMA Surg 2013;148: 849–58.
- Jafari MD, Wexner SD, Martz JE, McLemore EC, Margolin DA, Sherwinter DA, et al. Perfusion assessment in laparoscopic left-sided/anterior resection (PILLAR II): a multi-institutional study. J Am Coll Surg 2015;220: 82–92.
- Kirby A, Santoni N. Antibiotic resistance in Enterobacteriaceae: what impact on the efficacy of antibiotic prophylaxis in colorectal surgery? J Hosp Infect 2015;89:259–63.